

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of muscle hypertrophy (GO:0014741) | 9.61229314 |
| 2 | skeletal muscle tissue regeneration (GO:0043403) | 8.53384212 |
| 3 | actin-mediated cell contraction (GO:0070252) | 8.42744943 |
| 4 | response to muscle activity (GO:0014850) | 8.30813111 |
| 5 | regulation of skeletal muscle contraction (GO:0014819) | 8.28062569 |
| 6 | negative regulation of skeletal muscle tissue development (GO:0048642) | 7.86435269 |
| 7 | actin filament-based movement (GO:0030048) | 5.89458834 |
| 8 | cellular response to dexamethasone stimulus (GO:0071549) | 5.65983137 |
| 9 | response to activity (GO:0014823) | 5.59659495 |
| 10 | embryonic skeletal joint morphogenesis (GO:0060272) | 5.45800939 |
| 11 | skeletal muscle contraction (GO:0003009) | 5.38431318 |
| 12 | protein K6-linked ubiquitination (GO:0085020) | 5.38118212 |
| 13 | response to dexamethasone (GO:0071548) | 5.22330890 |
| 14 | cullin deneddylation (GO:0010388) | 5.15505206 |
| 15 | striated muscle adaptation (GO:0014888) | 4.99905555 |
| 16 | protein deneddylation (GO:0000338) | 4.72470514 |
| 17 | negative regulation of organelle assembly (GO:1902116) | 4.62226422 |
| 18 | maturation of SSU-rRNA (GO:0030490) | 4.37206582 |
| 19 | regulation of relaxation of muscle (GO:1901077) | 4.23684092 |
| 20 | muscle adaptation (GO:0043500) | 4.21707718 |
| 21 | muscle organ development (GO:0007517) | 4.20574041 |
| 22 | muscle structure development (GO:0061061) | 4.15147884 |
| 23 | muscle cell cellular homeostasis (GO:0046716) | 3.91953466 |
| 24 | regulation of muscle hypertrophy (GO:0014743) | 3.87976769 |
| 25 | protein polyglutamylation (GO:0018095) | 3.77227108 |
| 26 | negative regulation of histone acetylation (GO:0035067) | 3.75320648 |
| 27 | response to electrical stimulus (GO:0051602) | 3.63588020 |
| 28 | myotube cell development (GO:0014904) | 3.62557848 |
| 29 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.60839593 |
| 30 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.51442446 |
| 31 | organ induction (GO:0001759) | 3.50238737 |
| 32 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.48147623 |
| 33 | response to folic acid (GO:0051593) | 3.47238482 |
| 34 | myoblast fusion (GO:0007520) | 3.39310051 |
| 35 | striated muscle contraction (GO:0006941) | 3.34593766 |
| 36 | dosage compensation (GO:0007549) | 3.32759179 |
| 37 | protein trimerization (GO:0070206) | 3.30106285 |
| 38 | muscle system process (GO:0003012) | 3.29644560 |
| 39 | response to testosterone (GO:0033574) | 3.28611592 |
| 40 | muscle contraction (GO:0006936) | 3.24530498 |
| 41 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 3.23972432 |
| 42 | response to inactivity (GO:0014854) | 3.23188338 |
| 43 | regulation of centriole replication (GO:0046599) | 3.19589437 |
| 44 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.19033129 |
| 45 | negative regulation of striated muscle tissue development (GO:0045843) | 3.18526086 |
| 46 | regulation of sarcomere organization (GO:0060297) | 3.15793609 |
| 47 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.15574249 |
| 48 | tissue regeneration (GO:0042246) | 3.14205014 |
| 49 | postsynaptic membrane organization (GO:0001941) | 3.10424301 |
| 50 | negative regulation of muscle tissue development (GO:1901862) | 3.06889052 |
| 51 | skeletal muscle fiber development (GO:0048741) | 3.02175841 |
| 52 | regulation of DNA methylation (GO:0044030) | 2.97734549 |
| 53 | negative regulation of muscle organ development (GO:0048635) | 2.95576518 |
| 54 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.92969274 |
| 55 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.90853179 |
| 56 | regulation of striated muscle contraction (GO:0006942) | 2.84760763 |
| 57 | neuronal action potential propagation (GO:0019227) | 2.84682224 |
| 58 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.82794455 |
| 59 | cellular response to glucocorticoid stimulus (GO:0071385) | 2.80425364 |
| 60 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.80186493 |
| 61 | outer ear morphogenesis (GO:0042473) | 2.79632239 |
| 62 | proximal/distal pattern formation (GO:0009954) | 2.78178075 |
| 63 | ketone body metabolic process (GO:1902224) | 2.76091242 |
| 64 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.75332124 |
| 65 | protein-cofactor linkage (GO:0018065) | 2.70420012 |
| 66 | negative regulation of protein acetylation (GO:1901984) | 2.69865138 |
| 67 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.68381687 |
| 68 | cGMP-mediated signaling (GO:0019934) | 2.65672722 |
| 69 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.62798896 |
| 70 | lysine metabolic process (GO:0006553) | 2.61380614 |
| 71 | lysine catabolic process (GO:0006554) | 2.61380614 |
| 72 | metanephros development (GO:0001656) | 2.60364745 |
| 73 | cellular response to corticosteroid stimulus (GO:0071384) | 2.58250389 |
| 74 | plasma membrane fusion (GO:0045026) | 2.56347553 |
| 75 | cellular ketone body metabolic process (GO:0046950) | 2.54390481 |
| 76 | developmental induction (GO:0031128) | 2.52312826 |
| 77 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.51590081 |
| 78 | syncytium formation (GO:0006949) | 2.51421635 |
| 79 | skeletal muscle tissue development (GO:0007519) | 2.47362104 |
| 80 | lung secretory cell differentiation (GO:0061140) | 2.44127932 |
| 81 | cellular response to ketone (GO:1901655) | 2.43442655 |
| 82 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.42838180 |
| 83 | cell-cell signaling involved in cell fate commitment (GO:0045168) | 2.40810253 |
| 84 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.39336377 |
| 85 | regulation of muscle system process (GO:0090257) | 2.38358550 |
| 86 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.38037743 |
| 87 | retinal cone cell development (GO:0046549) | 2.37986324 |
| 88 | positive regulation of chondrocyte differentiation (GO:0032332) | 2.37560894 |
| 89 | appendage development (GO:0048736) | 2.36644377 |
| 90 | limb development (GO:0060173) | 2.36644377 |
| 91 | regulation of histone H3-K9 methylation (GO:0051570) | 2.36627321 |
| 92 | behavioral response to nicotine (GO:0035095) | 2.34932051 |
| 93 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.31661513 |
| 94 | sarcomere organization (GO:0045214) | 2.26394984 |
| 95 | response to gravity (GO:0009629) | 12.4313345 |
| 96 | striated muscle atrophy (GO:0014891) | 11.5895784 |
| 97 | skeletal muscle adaptation (GO:0043501) | 11.3285695 |
| 98 | muscle atrophy (GO:0014889) | 10.6269586 |
| 99 | actin-myosin filament sliding (GO:0033275) | 10.2097817 |
| 100 | muscle filament sliding (GO:0030049) | 10.2097817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_22108803_ChIP-Seq_LS180_Human | 7.16220341 |
| 2 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 5.38106924 |
| 3 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 4.98934337 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.11714724 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.84633979 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.55558502 |
| 7 | FUS_26573619_Chip-Seq_HEK293_Human | 2.90867582 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.71389349 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.67964610 |
| 10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.47701789 |
| 11 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.47633054 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.44237406 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.29901056 |
| 14 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.20009482 |
| 15 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.04274145 |
| 16 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.04183409 |
| 17 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 2.00263550 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.97650225 |
| 19 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.93048686 |
| 20 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.90843294 |
| 21 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.88553969 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.82064989 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.78701085 |
| 24 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.77688913 |
| 25 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.75790038 |
| 26 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.70555080 |
| 27 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.65615512 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.63884179 |
| 29 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.63039864 |
| 30 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.59038344 |
| 31 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.58699373 |
| 32 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.56901053 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.55124333 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.54614129 |
| 35 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.54232089 |
| 36 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.49739068 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.49459721 |
| 38 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.48312976 |
| 39 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46183444 |
| 40 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.46183444 |
| 41 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.46147863 |
| 42 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.44941436 |
| 43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39858950 |
| 44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39300498 |
| 45 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.38063642 |
| 46 | KDM2B_26808549_Chip-Seq_REH_Human | 1.35943359 |
| 47 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.29065963 |
| 48 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.27230003 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26512330 |
| 50 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.26283595 |
| 51 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.23875221 |
| 52 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.23567721 |
| 53 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.21758311 |
| 54 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.21388774 |
| 55 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.17252379 |
| 56 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.16111357 |
| 57 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.13346841 |
| 58 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.10725855 |
| 59 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.09913959 |
| 60 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.07576841 |
| 61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07355870 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06913345 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.06176131 |
| 64 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.04060547 |
| 65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02516601 |
| 66 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01193171 |
| 67 | EWS_26573619_Chip-Seq_HEK293_Human | 1.00626105 |
| 68 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99549665 |
| 69 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99316206 |
| 70 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.97346857 |
| 71 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.97205902 |
| 72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96046313 |
| 73 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95938746 |
| 74 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93780138 |
| 75 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.92733973 |
| 76 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.91752627 |
| 77 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.91274983 |
| 78 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.91067081 |
| 79 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.90713995 |
| 80 | TCF4_23295773_ChIP-Seq_U87_Human | 0.90382025 |
| 81 | AR_20517297_ChIP-Seq_VCAP_Human | 0.88898238 |
| 82 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.87664026 |
| 83 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.86815072 |
| 84 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85992898 |
| 85 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85027453 |
| 86 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.84742143 |
| 87 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84304845 |
| 88 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.83639179 |
| 89 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.82763706 |
| 90 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81963899 |
| 91 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.81873252 |
| 92 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.81347017 |
| 93 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.81223186 |
| 94 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.81167238 |
| 95 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.81167238 |
| 96 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.80539283 |
| 97 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.78863178 |
| 98 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.78326940 |
| 99 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.78326940 |
| 100 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.77476879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000749_muscle_degeneration | 4.88531709 |
| 2 | MP0000747_muscle_weakness | 4.66909430 |
| 3 | MP0004145_abnormal_muscle_electrophysio | 4.49941018 |
| 4 | MP0004036_abnormal_muscle_relaxation | 3.68278813 |
| 5 | MP0002269_muscular_atrophy | 3.38720013 |
| 6 | MP0002638_abnormal_pupillary_reflex | 3.19111615 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.98812073 |
| 8 | MP0000759_abnormal_skeletal_muscle | 2.93020255 |
| 9 | MP0000372_irregular_coat_pigmentation | 2.91155777 |
| 10 | MP0002089_abnormal_postnatal_growth/wei | 2.88762883 |
| 11 | MP0004270_analgesia | 2.57267714 |
| 12 | MP0002108_abnormal_muscle_morphology | 2.47492010 |
| 13 | MP0003950_abnormal_plasma_membrane | 2.46905146 |
| 14 | MP0002095_abnormal_skin_pigmentation | 2.46606945 |
| 15 | MP0005620_abnormal_muscle_contractility | 2.43494321 |
| 16 | MP0000751_myopathy | 2.32096491 |
| 17 | MP0003123_paternal_imprinting | 2.28247464 |
| 18 | MP0004087_abnormal_muscle_fiber | 2.26559258 |
| 19 | MP0005171_absent_coat_pigmentation | 2.22696253 |
| 20 | MP0002106_abnormal_muscle_physiology | 2.09329975 |
| 21 | MP0005083_abnormal_biliary_tract | 2.09178250 |
| 22 | MP0004084_abnormal_cardiac_muscle | 2.06224536 |
| 23 | MP0003880_abnormal_central_pattern | 2.04947882 |
| 24 | MP0003122_maternal_imprinting | 1.84273664 |
| 25 | MP0000733_abnormal_muscle_development | 1.81265684 |
| 26 | MP0005369_muscle_phenotype | 1.72573237 |
| 27 | MP0002736_abnormal_nociception_after | 1.69710063 |
| 28 | MP0005408_hypopigmentation | 1.66328520 |
| 29 | MP0003937_abnormal_limbs/digits/tail_de | 1.55518635 |
| 30 | MP0000427_abnormal_hair_cycle | 1.54262226 |
| 31 | MP0000566_synostosis | 1.52560628 |
| 32 | MP0003646_muscle_fatigue | 1.50742447 |
| 33 | MP0004147_increased_porphyrin_level | 1.50742140 |
| 34 | MP0003136_yellow_coat_color | 1.47638364 |
| 35 | MP0002102_abnormal_ear_morphology | 1.47251281 |
| 36 | MP0009250_abnormal_appendicular_skeleto | 1.40190391 |
| 37 | MP0004484_altered_response_of | 1.35602046 |
| 38 | MP0003011_delayed_dark_adaptation | 1.35330164 |
| 39 | MP0010030_abnormal_orbit_morphology | 1.31842351 |
| 40 | MP0009697_abnormal_copulation | 1.28931881 |
| 41 | MP0000750_abnormal_muscle_regeneration | 1.22455412 |
| 42 | MP0003385_abnormal_body_wall | 1.20379025 |
| 43 | MP0001968_abnormal_touch/_nociception | 1.19642686 |
| 44 | MP0005075_abnormal_melanosome_morpholog | 1.16609198 |
| 45 | MP0000049_abnormal_middle_ear | 1.15024814 |
| 46 | MP0004215_abnormal_myocardial_fiber | 1.13404643 |
| 47 | MP0001661_extended_life_span | 1.12488382 |
| 48 | MP0003959_abnormal_lean_body | 1.09961458 |
| 49 | MP0009780_abnormal_chondrocyte_physiolo | 1.09612443 |
| 50 | MP0003755_abnormal_palate_morphology | 1.05860995 |
| 51 | MP0000467_abnormal_esophagus_morphology | 1.03653320 |
| 52 | MP0005423_abnormal_somatic_nervous | 1.02845541 |
| 53 | MP0002896_abnormal_bone_mineralization | 1.00485629 |
| 54 | MP0005253_abnormal_eye_physiology | 1.00475157 |
| 55 | MP0000579_abnormal_nail_morphology | 0.92366983 |
| 56 | MP0008789_abnormal_olfactory_epithelium | 0.91992532 |
| 57 | MP0004133_heterotaxia | 0.90563971 |
| 58 | MP0002177_abnormal_outer_ear | 0.90476071 |
| 59 | MP0002114_abnormal_axial_skeleton | 0.89899136 |
| 60 | MP0002938_white_spotting | 0.88764222 |
| 61 | MP0003878_abnormal_ear_physiology | 0.88278460 |
| 62 | MP0005377_hearing/vestibular/ear_phenot | 0.88278460 |
| 63 | MP0000569_abnormal_digit_pigmentation | 0.87233267 |
| 64 | MP0005248_abnormal_Harderian_gland | 0.81919028 |
| 65 | MP0010234_abnormal_vibrissa_follicle | 0.81812535 |
| 66 | MP0010307_abnormal_tumor_latency | 0.81665050 |
| 67 | MP0003121_genomic_imprinting | 0.81326305 |
| 68 | MP0006072_abnormal_retinal_apoptosis | 0.80179284 |
| 69 | MP0002075_abnormal_coat/hair_pigmentati | 0.79591792 |
| 70 | MP0002127_abnormal_cardiovascular_syste | 0.79333774 |
| 71 | MP0005174_abnormal_tail_pigmentation | 0.79207895 |
| 72 | MP0002822_catalepsy | 0.78151158 |
| 73 | MP0004043_abnormal_pH_regulation | 0.76661201 |
| 74 | MP0000778_abnormal_nervous_system | 0.76259270 |
| 75 | MP0003942_abnormal_urinary_system | 0.75407421 |
| 76 | MP0002734_abnormal_mechanical_nocicepti | 0.75243238 |
| 77 | MP0001243_abnormal_dermal_layer | 0.74266767 |
| 78 | MP0002109_abnormal_limb_morphology | 0.74165331 |
| 79 | MP0000015_abnormal_ear_pigmentation | 0.73851592 |
| 80 | MP0002115_abnormal_skeleton_extremities | 0.70182073 |
| 81 | MP0000631_abnormal_neuroendocrine_gland | 0.68790119 |
| 82 | MP0001293_anophthalmia | 0.68765416 |
| 83 | MP0003941_abnormal_skin_development | 0.68600952 |
| 84 | MP0005275_abnormal_skin_tensile | 0.68397724 |
| 85 | MP0000534_abnormal_ureter_morphology | 0.68309232 |
| 86 | MP0001529_abnormal_vocalization | 0.66555074 |
| 87 | MP0002233_abnormal_nose_morphology | 0.66109013 |
| 88 | MP0003045_fibrosis | 0.65553326 |
| 89 | MP0005551_abnormal_eye_electrophysiolog | 0.65125788 |
| 90 | MP0005646_abnormal_pituitary_gland | 0.64475474 |
| 91 | MP0001984_abnormal_olfaction | 0.61865668 |
| 92 | MP0002116_abnormal_craniofacial_bone | 0.61682486 |
| 93 | MP0000377_abnormal_hair_follicle | 0.60755375 |
| 94 | MP0003786_premature_aging | 0.59991160 |
| 95 | MP0001502_abnormal_circadian_rhythm | 0.59592207 |
| 96 | MP0002972_abnormal_cardiac_muscle | 0.59362192 |
| 97 | MP0002277_abnormal_respiratory_mucosa | 0.58509216 |
| 98 | MP0000537_abnormal_urethra_morphology | 0.58038418 |
| 99 | MP0002249_abnormal_larynx_morphology | 0.57983600 |
| 100 | MP0000371_diluted_coat_color | 0.55093008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Distal arthrogryposis (HP:0005684) | 7.20648446 |
| 2 | Palpebral edema (HP:0100540) | 6.58839310 |
| 3 | Absent phalangeal crease (HP:0006109) | 6.51506123 |
| 4 | Ulnar deviation of the wrist (HP:0003049) | 6.50269751 |
| 5 | Deformed tarsal bones (HP:0008119) | 6.23799413 |
| 6 | Nemaline bodies (HP:0003798) | 6.10848012 |
| 7 | Round ear (HP:0100830) | 5.94061368 |
| 8 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.53865344 |
| 9 | Exercise-induced myalgia (HP:0003738) | 5.53019006 |
| 10 | Calcaneovalgus deformity (HP:0001848) | 5.49908748 |
| 11 | Abnormal finger flexion creases (HP:0006143) | 5.44124470 |
| 12 | Muscle fiber inclusion bodies (HP:0100299) | 5.43865327 |
| 13 | Mask-like facies (HP:0000298) | 5.04967202 |
| 14 | Exercise-induced muscle cramps (HP:0003710) | 4.56174684 |
| 15 | Type 2 muscle fiber atrophy (HP:0003554) | 4.47901423 |
| 16 | Muscle fiber atrophy (HP:0100295) | 4.00017384 |
| 17 | Hyperkalemia (HP:0002153) | 3.97143143 |
| 18 | Type 1 muscle fiber predominance (HP:0003803) | 3.71424501 |
| 19 | Fibular aplasia (HP:0002990) | 3.53598445 |
| 20 | Popliteal pterygium (HP:0009756) | 3.42164169 |
| 21 | Malignant hyperthermia (HP:0002047) | 3.33059421 |
| 22 | Myopathic facies (HP:0002058) | 3.16156142 |
| 23 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 3.07127860 |
| 24 | Abnormality of the neuromuscular junction (HP:0003398) | 3.05594179 |
| 25 | Fatigable weakness (HP:0003473) | 3.05594179 |
| 26 | Periorbital edema (HP:0100539) | 3.00643455 |
| 27 | Myotonia (HP:0002486) | 2.98939887 |
| 28 | Weak cry (HP:0001612) | 2.92525488 |
| 29 | Myoglobinuria (HP:0002913) | 2.86967433 |
| 30 | Facial edema (HP:0000282) | 2.83655207 |
| 31 | Nonprogressive disorder (HP:0003680) | 2.83345749 |
| 32 | Abnormality of the calcaneus (HP:0008364) | 2.78336147 |
| 33 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.67781387 |
| 34 | Down-sloping shoulders (HP:0200021) | 2.62360265 |
| 35 | Adactyly (HP:0009776) | 2.54171424 |
| 36 | Mesomelia (HP:0003027) | 2.50896189 |
| 37 | Abnormality of placental membranes (HP:0011409) | 2.35453366 |
| 38 | Amniotic constriction ring (HP:0009775) | 2.35453366 |
| 39 | Microglossia (HP:0000171) | 2.30473707 |
| 40 | Gowers sign (HP:0003391) | 2.26854585 |
| 41 | Neoplasm of the heart (HP:0100544) | 2.26646532 |
| 42 | Rectal prolapse (HP:0002035) | 2.22045754 |
| 43 | Metatarsus adductus (HP:0001840) | 2.21552593 |
| 44 | Muscle stiffness (HP:0003552) | 2.20116825 |
| 45 | Abnormality of potassium homeostasis (HP:0011042) | 2.16424223 |
| 46 | Increased connective tissue (HP:0009025) | 2.07827750 |
| 47 | Hyporeflexia of lower limbs (HP:0002600) | 2.03031357 |
| 48 | Abnormality of alanine metabolism (HP:0010916) | 1.98232751 |
| 49 | Hyperalaninemia (HP:0003348) | 1.98232751 |
| 50 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.98232751 |
| 51 | Aplasia of the musculature (HP:0100854) | 1.97350174 |
| 52 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.96228497 |
| 53 | Abnormality of the 2nd finger (HP:0004100) | 1.93829102 |
| 54 | Coronal craniosynostosis (HP:0004440) | 1.92715575 |
| 55 | 2-3 toe syndactyly (HP:0004691) | 1.92190420 |
| 56 | Synostosis involving bones of the feet (HP:0009140) | 1.90102179 |
| 57 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.90102179 |
| 58 | 3-Methylglutaconic aciduria (HP:0003535) | 1.90067318 |
| 59 | Calf muscle hypertrophy (HP:0008981) | 1.86711027 |
| 60 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.85118570 |
| 61 | Tarsal synostosis (HP:0008368) | 1.82475355 |
| 62 | Methylmalonic acidemia (HP:0002912) | 1.82396644 |
| 63 | Rhabdomyolysis (HP:0003201) | 1.81945916 |
| 64 | Delayed CNS myelination (HP:0002188) | 1.81691254 |
| 65 | Hyperglycinemia (HP:0002154) | 1.81428118 |
| 66 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.77270076 |
| 67 | Neonatal respiratory distress (HP:0002643) | 1.76791504 |
| 68 | Methylmalonic aciduria (HP:0012120) | 1.75389360 |
| 69 | Abnormality of the calf musculature (HP:0001430) | 1.74423931 |
| 70 | Ulnar deviation of finger (HP:0009465) | 1.74263705 |
| 71 | Easy fatigability (HP:0003388) | 1.73288578 |
| 72 | Acute necrotizing encephalopathy (HP:0006965) | 1.70616778 |
| 73 | Difficulty running (HP:0009046) | 1.67894756 |
| 74 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.64907573 |
| 75 | Neck muscle weakness (HP:0000467) | 1.64555637 |
| 76 | Decreased circulating renin level (HP:0003351) | 1.64207227 |
| 77 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.61469990 |
| 78 | Cerebral hypomyelination (HP:0006808) | 1.61246161 |
| 79 | Progressive macrocephaly (HP:0004481) | 1.60674933 |
| 80 | Hepatocellular necrosis (HP:0001404) | 1.60599113 |
| 81 | Short tibia (HP:0005736) | 1.60116890 |
| 82 | Webbed neck (HP:0000465) | 1.58416059 |
| 83 | Poor suck (HP:0002033) | 1.58145122 |
| 84 | Unsteady gait (HP:0002317) | 1.58021921 |
| 85 | Short phalanx of the thumb (HP:0009660) | 1.54618253 |
| 86 | Pterygium (HP:0001059) | 1.52885551 |
| 87 | Broad hallux (HP:0010055) | 1.52189732 |
| 88 | Asplenia (HP:0001746) | 1.51876314 |
| 89 | Abnormal number of incisors (HP:0011064) | 1.51714109 |
| 90 | Acute encephalopathy (HP:0006846) | 1.49880344 |
| 91 | Adducted thumb (HP:0001181) | 1.49519541 |
| 92 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.49423741 |
| 93 | Increased CSF lactate (HP:0002490) | 1.49044191 |
| 94 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.48969166 |
| 95 | Fetal akinesia sequence (HP:0001989) | 1.48899147 |
| 96 | Hepatic necrosis (HP:0002605) | 1.46507205 |
| 97 | Congenital stationary night blindness (HP:0007642) | 1.45987505 |
| 98 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.45687829 |
| 99 | Mitochondrial inheritance (HP:0001427) | 1.44788732 |
| 100 | Generalized muscle weakness (HP:0003324) | 1.42863781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK2 | 5.49123908 |
| 2 | OBSCN | 4.13040076 |
| 3 | MAP4K2 | 3.74237521 |
| 4 | MUSK | 3.69026406 |
| 5 | PHKG1 | 3.54281747 |
| 6 | PHKG2 | 3.54281747 |
| 7 | TIE1 | 3.24033605 |
| 8 | WNK4 | 2.73662480 |
| 9 | PBK | 2.64629116 |
| 10 | CCNB1 | 2.39263740 |
| 11 | MAPK13 | 2.25824656 |
| 12 | ARAF | 2.07310316 |
| 13 | NUAK1 | 1.94247945 |
| 14 | CAMK1D | 1.92343395 |
| 15 | CAMK1G | 1.84775941 |
| 16 | STK16 | 1.80179410 |
| 17 | LIMK1 | 1.79554107 |
| 18 | WNK1 | 1.64550154 |
| 19 | PIK3CG | 1.62805314 |
| 20 | EIF2AK1 | 1.62725309 |
| 21 | SRPK1 | 1.61290150 |
| 22 | PRKD3 | 1.53625830 |
| 23 | DYRK2 | 1.51968794 |
| 24 | CDK19 | 1.51711550 |
| 25 | IRAK1 | 1.51158212 |
| 26 | EIF2AK3 | 1.48144459 |
| 27 | NEK1 | 1.33669857 |
| 28 | PIK3CA | 1.24214846 |
| 29 | BCKDK | 1.21917269 |
| 30 | MKNK2 | 1.21308579 |
| 31 | CAMKK2 | 1.20232216 |
| 32 | TAOK3 | 1.14174857 |
| 33 | CHEK2 | 1.14003632 |
| 34 | TAF1 | 1.12861067 |
| 35 | JAK3 | 1.10803645 |
| 36 | BMPR1B | 1.10383395 |
| 37 | STK39 | 1.06813607 |
| 38 | FRK | 0.96027129 |
| 39 | MARK3 | 0.94748706 |
| 40 | CDK4 | 0.94713619 |
| 41 | CAMK2G | 0.92258505 |
| 42 | MAPK7 | 0.86079453 |
| 43 | CSNK1G1 | 0.85722342 |
| 44 | MKNK1 | 0.85024883 |
| 45 | MAP2K4 | 0.84945849 |
| 46 | PRKG2 | 0.84890213 |
| 47 | CASK | 0.81303347 |
| 48 | AURKA | 0.77321875 |
| 49 | RAF1 | 0.76291240 |
| 50 | PINK1 | 0.76109975 |
| 51 | EPHA4 | 0.73857241 |
| 52 | MAP2K7 | 0.73436181 |
| 53 | CSNK1A1L | 0.72702914 |
| 54 | CSNK1G2 | 0.71008280 |
| 55 | VRK1 | 0.67558570 |
| 56 | BUB1 | 0.67374353 |
| 57 | CSNK1G3 | 0.63261676 |
| 58 | EIF2AK2 | 0.61629038 |
| 59 | TYRO3 | 0.58567307 |
| 60 | PTK2B | 0.56723281 |
| 61 | DYRK1B | 0.56711687 |
| 62 | PRKG1 | 0.56570167 |
| 63 | PIM2 | 0.56293394 |
| 64 | VRK2 | 0.55656969 |
| 65 | OXSR1 | 0.55554718 |
| 66 | BRAF | 0.54803262 |
| 67 | WNK3 | 0.54481573 |
| 68 | MAPK12 | 0.51182030 |
| 69 | AKT2 | 0.48672008 |
| 70 | MOS | 0.48362871 |
| 71 | ZAK | 0.47545693 |
| 72 | ILK | 0.45105955 |
| 73 | MAP3K4 | 0.39395184 |
| 74 | CAMK1 | 0.38607301 |
| 75 | NEK9 | 0.37023956 |
| 76 | PNCK | 0.36626551 |
| 77 | DMPK | 0.36197820 |
| 78 | ATR | 0.34533448 |
| 79 | LRRK2 | 0.31622622 |
| 80 | PKN1 | 0.31552456 |
| 81 | MAP3K10 | 0.31176934 |
| 82 | GRK1 | 0.30437946 |
| 83 | NME2 | 0.27696748 |
| 84 | CAMKK1 | 0.27318614 |
| 85 | DYRK3 | 0.25806519 |
| 86 | PRKACA | 0.24659300 |
| 87 | IRAK2 | 0.23759033 |
| 88 | CSNK2A1 | 0.22128673 |
| 89 | SGK1 | 0.21974352 |
| 90 | RPS6KA5 | 0.21419871 |
| 91 | NTRK2 | 0.20838090 |
| 92 | NEK6 | 0.20417008 |
| 93 | PRKCE | 0.20110285 |
| 94 | ADRBK2 | 0.19055817 |
| 95 | INSRR | 0.18523292 |
| 96 | FGFR2 | 0.18383935 |
| 97 | PLK1 | 0.18330458 |
| 98 | TTK | 0.17681578 |
| 99 | CDK5 | 0.15427349 |
| 100 | ATM | 0.15205252 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.78836452 |
| 2 | Tight junction_Homo sapiens_hsa04530 | 3.56668470 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.76875183 |
| 4 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.68497826 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.19446780 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.11287767 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.04152828 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.02154721 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.84858965 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.84580032 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.76707591 |
| 12 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.71514614 |
| 13 | Basal transcription factors_Homo sapiens_hsa03022 | 1.70309845 |
| 14 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.68005335 |
| 15 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.67281807 |
| 16 | Sulfur relay system_Homo sapiens_hsa04122 | 1.66601595 |
| 17 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.63775075 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.62570921 |
| 19 | Alzheimers disease_Homo sapiens_hsa05010 | 1.62442438 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.62158831 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.54305323 |
| 22 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.47359658 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.47017813 |
| 24 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.46253723 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.41073029 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.39040437 |
| 27 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.38766357 |
| 28 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.38473049 |
| 29 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38269057 |
| 30 | Proteasome_Homo sapiens_hsa03050 | 1.36600171 |
| 31 | RNA degradation_Homo sapiens_hsa03018 | 1.36574371 |
| 32 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.34846039 |
| 33 | RNA polymerase_Homo sapiens_hsa03020 | 1.33836479 |
| 34 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.33594263 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32266430 |
| 36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.31471797 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.27495769 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.24562972 |
| 39 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.24370962 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.20444827 |
| 41 | Olfactory transduction_Homo sapiens_hsa04740 | 1.19995176 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.18103205 |
| 43 | RNA transport_Homo sapiens_hsa03013 | 1.04758979 |
| 44 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.01873910 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95449221 |
| 46 | Circadian rhythm_Homo sapiens_hsa04710 | 0.95171394 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.93955508 |
| 48 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.93932868 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93199914 |
| 50 | Circadian entrainment_Homo sapiens_hsa04713 | 0.92184059 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.90776829 |
| 52 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.90568752 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90534221 |
| 54 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.88916640 |
| 55 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.85450911 |
| 56 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.83200542 |
| 57 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83097228 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.81187514 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.75173242 |
| 60 | Purine metabolism_Homo sapiens_hsa00230 | 0.75150365 |
| 61 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.75077509 |
| 62 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74499651 |
| 63 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.73390416 |
| 64 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.72863659 |
| 65 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.71775996 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.71160065 |
| 67 | Insulin secretion_Homo sapiens_hsa04911 | 0.70683129 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.69501171 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69437930 |
| 70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67893216 |
| 71 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67755732 |
| 72 | Spliceosome_Homo sapiens_hsa03040 | 0.67102519 |
| 73 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66402928 |
| 74 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.64928061 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.64464116 |
| 76 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.63830318 |
| 77 | Morphine addiction_Homo sapiens_hsa05032 | 0.61418403 |
| 78 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.56735672 |
| 79 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.54150447 |
| 80 | Axon guidance_Homo sapiens_hsa04360 | 0.53236079 |
| 81 | Taste transduction_Homo sapiens_hsa04742 | 0.53229726 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53014773 |
| 83 | Melanogenesis_Homo sapiens_hsa04916 | 0.51493968 |
| 84 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.50392977 |
| 85 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48109059 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.46666483 |
| 87 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.45415877 |
| 88 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.44424627 |
| 89 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44305136 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38947846 |
| 91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.35928431 |
| 92 | Alcoholism_Homo sapiens_hsa05034 | 0.35438865 |
| 93 | GABAergic synapse_Homo sapiens_hsa04727 | 0.34772113 |
| 94 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.34511839 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33833100 |
| 96 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.32030382 |
| 97 | Homologous recombination_Homo sapiens_hsa03440 | 0.31482529 |
| 98 | Retinol metabolism_Homo sapiens_hsa00830 | 0.30554861 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.30023353 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29135788 |

